GetTopicDetailResponse(id=0e6812680545, topicName=KRASG12C抑制劑, introduction=, content=KRASG12C抑制劑, image=null, comments=0, allHits=86, url=null, type=0, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Mon May 12 14:47:47 CST 2025, time=2025-05-12, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=504394, tagList=[TagDto(tagId=504394, tagName=KRASG12C抑制劑)], ipAttribution=上海, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2264663, encodeId=140a2264663b5, content=<a href='/topic/show?id=0e6812680545' target=_blank style='color:#2F92EE;'>#KRASG12C抑制劑#</a>, objectTitle=《自然-醫(yī)學(xué)》：73%患者客觀緩解！新藥對(duì)肺癌、結(jié)直腸癌等實(shí)體瘤均有效，下一代KRAS抑制劑前景廣闊, objectType=article, longId=875670, objectId=c3738e5670ee, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240517/1715928705356_5579292.jpg, objectUrl=/article/show_article.do?id=c3738e5670ee, replyNumber=0, likeNumber=28, createdTime=2025-05-12, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=c3738e5670ee, moduleTitle=《自然-醫(yī)學(xué)》：73%患者客觀緩解！新藥對(duì)肺癌、結(jié)直腸癌等實(shí)體瘤均有效，下一代KRAS抑制劑前景廣闊, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=c3738e5670ee)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2025-05-12發(fā)表于上海
